Welsh Pharmacy Review is Wales’s only regional healthcare magazine that is exclusively accessible to healthcare professionals. In order to further proceed, please use the drop-down menu below to submit your details. An email containing your password and link will authorise you to download the magazine. Saving your password on your device will save time in future.
Record investment and training opportunities as NHS Wales grows
A massive £260 million investment will boost training and help [...]
-
Lupin’s Namuscla® (mexiletine) is recommended by NICE for treatment of symptomatic myotonia in adults with non-dystrophic myotonic disorders (NDM) GalleryLupin’s Namuscla® (mexiletine) is recommended by NICE for treatment of symptomatic myotonia in adults with non-dystrophic myotonic disorders (NDM)
Lupin’s Namuscla® (mexiletine) is recommended by NICE for treatment of symptomatic myotonia in adults with non-dystrophic myotonic disorders (NDM)
Slough, UK, 4 November 2021: Global pharma major Lupin today announces [...]
Register for the first #LivingDiabetesTogether webinar!
Living Diabetes together – Starting insulin Tuesday, November 9th, 2021 [...]
J&J Webinar Invitation: Children’s Healthcare: Overview & Guidance for Recommendation
Discover how to offer better support and guidance on children’s [...]
System C acquires WellSky International
System C Healthcare (“System C”) is pleased to announce that [...]
RPS Wales welcomes electronic prescribing plans
RPS Wales has welcomed an announcement by the Welsh Government to push [...]
